Studies on the efficacy of Sarafin® (sarafloxacin hydrochloride) on vibrios associated with vibriosis in black tiger shrimp (Penaeus monodon)
MetadataShow full item record
In vitro activity of Sarafin® (sarafloxacin hydrochloride) was determind againts 7 luminous Vibrio harveyi isolates and 3 non-luminous Vibrio species (V. parahaemolyticus, V. alginlyticus and Vibrio species) isolated from diseased marine shrimp (Penaeus monodon) and rearing water, a strain of V. anguillarum from diseased marine fish, I strain each of V. alginolyticus, V. vulnificus, and V. mimicus from diseased grouper (Epinephelus coioides), and V. alginolyticus from diseased seabass (Lates calcarifer). Bacterial susceptibility was expressed as minimum inhabitory concentration (MIC) and minimum bactericidal concentration (MBC). The MIC and MBC values obtained for all V. harveyi isolates ranged from <0.3 to 1.25µg/ml. For the non-luminous vibrio species, MIC and MBC values ranged from <0.08 to 1.25µg/ml. In vivo tolerance level (24 h static bioassay) of larval and postlarval stage of P. monodon for Sarafin® were ≤10 µg/ml for nauplii, mysis, and postlarvae and ≤1 µg/ml for zoeae. Morphological deformities in the carapace, rostrum, and setae were noted among larvae exposed to ≤50 µg/m Sarafin®. These results indicate that Sarafin® is a potential candidate as a chemotherapeutic agent againts luminous vibriosis in P. monodon.
In: Lavilla-Pitogo, C. R., Cruz-Lacierda, E. R. (Eds.). Diseases in Asian Aquaculture IV. Proceedings of the Fourth Symposium on Diseases in Asian Aquaculture, 22-26 November 1999, Cebu City, Philippines. Quezon City, Philippines: Fish Health Section, Asian Fisheries Society. pp. 125-134
PublisherFish Health Section, Asian Fisheries Society
Crustacea; Shrimp culture; Bacterial diseases; Disease control; Toxicity tolerance; Bioassays; Bacteriocides; Philippines; Shrimps; Bacteria; Giant tiger shrimp; Penaeus monodon; Vibrio alginolyticus; Vibrio anguillarum; Vibrio spp.; Vibrio harveyi; Vibrio parahaemolyticus; Vibrio vulnificus; Vibrio mimicus
Showing items related by title, author, creator and subject.
ArticleFrom January 1990 to June 1993, 59% of the total juvenile to adult shrimp (Penaeus monodon) submitted for diagnosis at the Fish Health Section of the Aquaculture Department, Southeast Asian Fisheries Development Center, Tigbauan, Iloilo, Philippines were diagnosed to have red disease syndrome. Red disease syndrome is characterized by the reddening of the shrimp body. The aetiology of the disease is unknown. This paper reports for the first time the isolation of four Vibrio phenotypes, namely, Vibrio harveyi, V. parahaemolyticus, V. fluuialis and Vibrio sp. from shrimps with red disease. Pathogenicity test shows that injection with V. parahaemolyticus and V. harveyi can produce the characteristic red discoloration in healthy shrimp.
Conference paperMG Bondad-Reantaso - In RV Pakingking Jr., EGT de Jesus-Ayson & BO Acosta (Eds.), Addressing Acute Hepatopancreatic Necrosis Disease (AHPND) and Other Transboundary Diseases for Improved Aquatic … Diseases for Improved Aquatic Animal Health in Southeast Asia, 22-24 February 2016, Makati City, Philippines, 2016 - Aquaculture Department, Southeast Asian Fisheries Development CenterThe Organization for Economic Cooperation and Development (OECD) and the Food and Agriculture Organization (FAO) of the United Nations Agricultural Outlook 2015-2024 reported that fisheries production worldwide is projected to expand by 19% between the 2012-14 base period and 2024, to reach 191 million metric tons (MT) and the main driver of this increase will be aquaculture, which is expected to reach 96 million MT by 2024, 38% higher than the base period (average 2012-14) level. Among the 7 key uncertainties that affect gains in productivity, the potential of animal disease outbreaks to affect aquaculture production and subsequently domestic and international markets are once again highlighted, although for the first time in this outlook. Another milestone document, the Blue frontiers: managing the environmental costs of aquaculture identified a number of fish health issues, including increased risk of the spread of pathogens and diseases with intensification, through increased movement of aquatic animals, inter-regional trade and introduction of new species and new strains, and through the use of trash fish or live feed; concerns on residues and development of drug resistant pathogens brought about by the abuse on the use antimicrobials and other veterinary drugs; limited availability of vaccines; environmental stressors that compromise the immune system; difficulties faced by developing countries in implementing international standards; and the need for legislation, enforcement and capacity building. The issues identified then and now are almost the same. Addressing animal health issues in aquaculture is very challenging because the sector is highly complex (with a wide range of diversity in terms of species, systems, practices and environment, each presenting different risks), its fluid environment, and the transboundary nature where fish is considered as one of the most traded commodity, aquatic animals require more attention in order to monitor their health: they are not visible except in tank holding conditions; they live in a complex and dynamic environment and feed consumption and mortalities are hidden under water. This paper looks at the status of a newly emerging disease of cultured shrimp, acute hepatopancreatic necrosis disease (AHPND), which has been recognized as the most important non-viral disease threat to cultured shrimp. In particular, this paper presents the highlights of the International Technical Seminar/Workshop: EMS/AHPND: Government, Scientist and Farmer Responses held from 22-24 June 2015 in Panama City, Panama, which was organized under the auspices of an FAO inter-regional project TCP/INT/3502: Reducing and Managing the Risks of AHPND of Cultured Shrimp, being participated by 11 countries, namely: Colombia, Ecuador, Guatemala, Honduras, Mexico, Panama and Peru from Latin America and the Caribbean (LAC) region and India, Iran, the Philippines and Sri Lanka from the Asian region. The Panama EMS/AHPND June 2015 event aimed to provide a platform to improve the understanding of the disease through the lens of governments, scientists and producers and collectively generate practical management and control measures. More than 100 stakeholders from 21 countries representing the government, academe and producer sectors participated in the event. The highlights contain the latest available information at that time (June 2015) about AHPND including the current state of knowledge about the causative agent, the host and geographical distribution, detection methods, risk factors, management and actions of regional and international organizations.
Conference paperEM Leaño - In RV Pakingking Jr., EGT de Jesus-Ayson & BO Acosta (Eds.), Addressing Acute Hepatopancreatic Necrosis Disease (AHPND) and Other Transboundary Diseases for Improved Aquatic … Diseases for Improved Aquatic Animal Health in Southeast Asia, 22-24 February 2016, Makati City, Philippines, 2016 - Aquaculture Department, Southeast Asian Fisheries Development CenterTransboundary aquatic animal diseases are among the major concerns for establishing biosecurity measures and strengthening of aquatic animal health (AAH) management capacity (including emergency preparedness) in the region. In aquaculture, biosecurity and AAH management entails protection of fish or shellfish from infectious agents (viral, bacterial, fungal or parasitic) as well as prevention of disease spread from one area to another. Several transboundary aquatic animal diseases have swept the region over the past 25 years causing massive economic and social losses. These include spread and outbreaks of epizootic ulcerative syndrome (EUS) in freshwater fish, viral nervous necrosis (VNN) in marine fish, viral haemorrhagic septicaemia (VHS) in marine and freshwater fish, and several viral diseases in shrimps (e.g. white spot disease [WSD], infectious haematopoietic necrosis [IHHN]). The spread of these transboundary diseases clearly demonstrates the vulnerability of the aquaculture industry to disease emergence where impacts have been aggravated by the lack of effective preparedness and response when diseases emerge. Recently, outbreaks of acute hepatopancreatic necrosis disease (AHPND), popularly known as early mortality syndrome (EMS), among cultured shrimps were reported in China and Viet Nam (2010), Malaysia (2011), Thailand (2012), Mexico (2013) and the Philippines (2014). There have been reports of its spread in South American countries but limited report is available in this regard. This disease caused significant losses in the production of Penaeus monodon and P. vannamei in the affected countries. NACA s regional response to this disease during its initial outbreak in Viet Nam, Thailand and Malaysia signified that improved control on transboundary diseases and emergency preparedness are still needed in the region. In collaboration with international organizations (OIE, FAO), NACA has implemented awareness programs, efficient information dissemination, and emergency regional expert consultation to address this disease problem. OIE and FAO also deployed experts to assess the disease and identify the pathogen involved. All of these efforts, together with subsequent studies on prevention and disease management, have paved the way in preventing further spread of this disease to other shrimp-producing countries so far. However, the risk is still very high that this disease will spread, as transboundary movement of live shrimps within and outside the region is inevitable. In addition, other emerging diseases are now affecting production of major cultured shrimps in the region. These include hepatopancreatic microsporidiosis (HPM) caused by Enterocytozoon hepatopenaei (EHP) with confirmed reports from China, Viet Nam, Thailand, Malaysia and Indonesia (unconfirmed reports from India), and viral covert mortality disease (VCMD) which was reported to be affecting cultured shrimps in China. By and large, outbreaks of damaging aquatic animal diseases are likely to continue and the potential consequences are likely to increase with the expansion (intensification) of aquaculture systems and introduction of new species for culture. Consequently, the risks associated with emerging and transboundary diseases are shared - shared water bodies and epidemiological links through trade (especially live movement) - thus, a collaborative approach in dealing with these diseases is therefore warranted and necessary.